Anzeige
Mehr »
Dienstag, 17.02.2026 - Börsentäglich über 12.000 News
Bio-Milliardenmarkt: Steht Organto vor der Neubewertung?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41XSS | ISIN: CA8605762068 | Ticker-Symbol:
Branche
Getränke/Tabak
Aktienmarkt
Sonstige
1-Jahres-Chart
STICKIT TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
STICKIT TECHNOLOGIES INC 5-Tage-Chart
PR Newswire
105 Leser
Artikel bewerten:
(0)

StickIt Technologies Inc.: StickIt Announces Closing of its Private Placement

NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, BC, Feb. 17, 2026 /PRNewswire/ -- StickIt Technologies Inc. (the "Company" or "STKT"), (CSE: STKT), a parent company of the Israeli technology and cannabinoid company StickIt Ltd., the developer exclusivity & patent protected of "Cannabis Sticks" Technology" is pleased to announce that it has closed its non-brokered private placement announced on October 16, 2025 and clarified on October 23, 2025 and December 31, 2025. The Company has issued a total of 28,884,000 units (each a "Unit") at a price of CDN$0.025 per unit, for gross proceeds of CDN$722,100.00. Each Unit consists of one common share and one full common share purchase warrant. Each warrant entitles the holder to purchase one additional common share of the Company at a price of CDN$0.025 per share for a period of thirty-six months up to and including February 13, 2029, subject to the exercise price restriction clause.

Stickit Logo

A finder's fee comprised of CDN$57,768.00 and 2,310,720 finder warrants (the "Finder Warrants") was paid on a portion of the financing. Each Finder warrant entitles the holder to purchase one additional common share of the Company at a price of CDN$0.025 per share for a period of thirty-six months up to and including February 13, 2029, subject to an exercise price restriction clause. Under the exercise price restriction clause, the Warrants and Finder's Warrants cannot be exercised until the Company completes a further consolidation of its share capital, with every two (2) existing shares consolidated into one (1) new share.

The Company is a Non-Venture Issuer and the number of securities issuable in the offering (calculated on a fully diluted basis) is more than 100% of the total number of securities or votes outstanding. The Company requested and was granted exemption from CSE Policy 4.6.2(a)(i)(2) since (i) the Company is in serious financial difficulty; (ii) the Company has reached an agreement to complete the Private Placement; (iii) no Related Person of the Company is participating in the Private Placement; (iv) independent directors constituting a majority of the Board's independent directors in a vote in which only independent directors participated, determined that the offering is in the best interests of the Company, is reasonable in the circumstances and that it is not feasible to obtain security holder approval; and (v) on December 31, 2025 the Company issued a news release stating it will not hold a security holder vote and fully explaining how it qualifies for the exception.

All securities issued are subject to a hold period of four (4) months and one day and as such may not be traded until June 14, 2026.

The net proceeds from the sale of units have been added to working capital in furtherance of the Company's business.

About StickIt

Stickit primary assets consist of patents and patent applications related to plant extracts, therapeutic compounds in smoking utensils, and honey complexes. StickIt have already patents granted in USA, Europe, Israel and Canada. The Extra-C stick is created through a unique proprietary process, resulting in condensed cannabis oil presented in a toothpick-like matrix, allowing for the easy conversion of regular cigarettes into cannabis or hemp cigarettes.

StickIt operates from key facilities situated in Dalton, Northern Israel, these facilities are central to the company's research, development, and manufacturing operations.

Stickit's operating model is to establish joint ventures in countries around the world where recreational cannabis is permitted. Each licensee/joint venture partner will establish a production facility in which they will add the cannabis content to sticks produced and supplied by Stickit. As part of those arrangements StickIt is expected to provide the joint venture with the know-how required to manufacture the finished product. The licensee/joint venture partner will produce the finished product, adding cannabis to the raw materials provided by StickIt, and will sell them either directly to the points of sale or through distributors The licensee is expected to pay a setup fee by investing the funds necessary to set up the local production facility. Each licensee will have exclusive rights to produce and market Stickit products in their designated territory

On behalf of the Board of Directors

/s/ "Eli Ben-Haroosh"

Eli Ben-Haroosh, CEO

For further information please contact:
Mr. Eli Ban-Haroosh at info@stickit-labs.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Forward Looking Statements
This news release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, are forward-looking statements. The Company provides no assurance that forward-looking statements and information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements or information. Accordingly, readers should not place undue reliance on forward-looking statements or information. The Company does not undertake to update any forward-looking statements, other than as required by law. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by StickIt. Readers are cautioned not to place undue reliance on forward looking statements.

Logo - https://mma.prnewswire.com/media/2258883/Stickit_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/stickit-announces-closing-of-its-private-placement-302689552.html

© 2026 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.